Cite
HARVARD Citation
Liebers, N. et al. (2022). Seroconversion Rates After the Second COVID-19 Vaccination in Patients With Systemic Light Chain (AL) amyloidosis. HemaSphere. 6 (3), pp. e688-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Liebers, N. et al. (2022). Seroconversion Rates After the Second COVID-19 Vaccination in Patients With Systemic Light Chain (AL) amyloidosis. HemaSphere. 6 (3), pp. e688-. [Online].